AttentiV Systems Group PLC
28 April 2005
Not for release, publication or distribution in, into or from Australia, Canada,
Japan or the United States
FOR IMMEDIATE RELEASE
28 April 2005
WITHDRAWAL OF RECOMMENDATION
Subsequent to the announcement released earlier today, the Board of AttentiV
Systems Group plc is withdrawing its recommendation from the TietoEnator offer
(as announced on 14 April 2005) in favour of the Microgen offer.
Enquiries
AttentiV Systems Group plc Tel: 01582 845000
Peter Bertram
David Webber
Hawkpoint (financial adviser to AttentiV) Tel: 020 7665 4500
Paul Baines
Graham Paton
Hawkpoint, which is authorised and regulated in the United Kingdom by the
Financial Services Authority, is acting exclusively as financial adviser to
AttentiV and no one else and will not be responsible to anyone other than
AttentiV for providing the protections afforded to clients of Hawkpoint, nor for
advising any other person in relation to the contents of this announcement or
any matter referred to herein.
Not for release, publication or distribution in, into or from Australia, Canada,
Japan or the United States.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.